+39 02 610346.1 - info@newron.com

Partners

Partners

Partnering is a key component of Newron’s strategy. We have developed alliances with leading pharmaceutical and biotech companies around the world and are active in talking to potential new partners on our promising pipeline of novel CNS and pain compounds. We are also looking to expand our portfolio through in-licensing or acquiring compounds focused on CNS disorders and pain, at various stages of development.